Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Naveris, Inc., a leader in molecular diagnostics for viral cancers, announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.
The...
Latham BioPharm Group, part of Sia Partners, is excited to announce the addition of a new capability centered around Digital Health Consulting. Digital transformation is...
Alpenglow Biosciences announced a collaboration with Mayo Clinic to integrate Alpenglow's 3D spatial biology platform to accelerate drug development and advance clinical diagnostics. Alpenglow has...